AI assistant
Sending…
Anixa Biosciences Inc — Director's Dealing 2024
Jun 18, 2024
34117_dirs_2024-06-18_6b1eacd3-4e6a-4be9-a0d6-bf0ec0cc03ff.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Anixa Biosciences Inc (ANIX)
CIK: 0000715446
Period of Report: 2024-06-14
Reporting Person: Titterton Lewis H jr (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-06-14 | Common Stock | P | 4000 | $2.68 | Acquired | 860612 | Direct |
More from Anixa Biosciences Inc
Regulatory Filings
2026
Mar 11
Interim / Quarterly Report
2026
Mar 9
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Jan 29
Proxy Solicitation & Information Statement
2026
Jan 28
Regulatory Filings
2026
Jan 12
Annual Report
2026
Jan 12
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6